Category: Antibody Technologies
Antibody Technologies market research reports by Frost & Sullivan
-
Engineered Antibody Therapeutics for Cancer
Engineered Antibody Therapeutics for Cancer Technology advances and increasing interest from Tier I pharmaceuticals are driving the growth of engineered antibodies This study analyzes the emergence of engineered antibody therapeutics for cancer, examining the factors driving their adoption. The limi ... Read More
-
Growth Opportunities in Drug Discovery and Early Development Outsourcing Services
Growth Opportunities in Drug Discovery and Early Development Outsourcing Services M&As, Partnerships, and the Shift Toward an End-to-end CRDMO Model will Boost Sector Expansion The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023 ... Read More
-
Innovation Waves in Immuno-oncology Therapy Development
Innovation Waves in Immuno-oncology Therapy Development Next-gen Cell Therapies and Precision Immunotherapies are Driving Growth and New Product Development Immuno-oncology (I-O) therapies target tumors by harnessing the host’s immune system. With the growing incidence and prevalence of various type ... Read More
-
Antibody-drug Conjugates: Technology Growth Opportunities
Antibody-drug Conjugates: Technology Growth Opportunities Antibody-drug conjugates (ADCs) are therapies that target cancer cells with antigen-specific antibodies and highly toxic payloads. ADCs are currently generating interest among drug developers, contract manufacturing companies, regulatory agen ... Read More
-
Technology Growth Opportunities for Exosome-Mediated Drug Delivery
Technology Growth Opportunities for Exosome-Mediated Drug Delivery Exosome-mediated drug delivery is a promising alternative to conventional drug delivery methods, making rapid strides in the biopharmaceutical industry because of the safety and efficacy advantages exosomes offer as nanocarriers over ... Read More
-
Global Antibody Therapeutics Growth Opportunities
Global Antibody Therapeutics Growth Opportunities Market growth is likely to be fueled by the growing utilization of cost-effective and efficient continuous manufacturing processes and single-use bioreactors for production, which will also reduce the time between development and commercialization. F ... Read More
Research Assistance
